BA Boeing Co

Previous close
$208.22
Est. 12 months change
+31.45%
Projected Price
$274.37

Profitability Metrics

Return on Equity (ROE)
290.08%
Return on Assets (ROA)
-0.29%
Return on Invested Capital (ROIC)
-9.74%
Weighted Average Cost of Capital (WACC)
9.59%
ROIC - WACC
-19.33%
Updated : 2026-04-03 21:58 ET

Valuation Metrics

P/E Ratio
93.78
Forward P/E
26134.93
PEG Ratio
17.54
Debt Current Ratio
1.19

Growth & Cash Flow

Gross Margin
4.81%
Operating Margin
-5.93%
FCF Margin
-2.11%
TTM Revenue Growth
57.12%
Projected 12M EPS Growth
-99.64%

Price Change

Price % from 50 SMA
-7.12%
Price % from 200 SMA
-4.76%
6 Months
-4.24%
1 Year
23.53%
2 Years
10.73%
Click here to see the list of ETFs containing BA as a top holding :Boeing Co ETFs

Analysis

Company Overview

Boeing manufactures commercial jetliners, military aircraft, satellites, and defense systems, operating amid an ongoing recovery from safety and production challenges. Sector: Industrials.

Overview

Boeing Co (BA) is an individual stock. The analysis below presents key financial metrics for the company, covering profitability, capital efficiency, valuation, margins, and growth.

Profitability & Capital Efficiency

Looking at how effectively the company deploy capital, ROIC is -9.74%, WACC is 9.59%, and the economic spread is -19.33%. On balance, capital is being deployed at rates below what debt and equity holders require, a headwind to long-term value creation if sustained. Supporting metrics show ROE at 290.08% and ROA at -0.29%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a company that likely needs operating improvement before returns quality can be considered durable.

Valuation

On an earnings multiple basis, trailing P/E of 93.78, forward P/E of 26134.93, PEG of 17.54. The gap between trailing and forward multiples is not especially wide, suggesting the market is pricing a steadier earnings path rather than a sharp near-term re-rating. The PEG ratio is elevated, suggesting investors are paying a premium for the growth embedded in current earnings estimates. A current ratio reading of 1.19 suggests the company carries less short-term financial cushion than the broader market average. Combining multiples and liquidity, the company appears adequately priced for its current earnings trajectory, with balance sheet health providing a degree of downside resilience.

Margins & Cash Generation

Across the three margin layers, gross margin sits at 4.81%, operating margin at -5.93%, and free cash flow margin at -2.11%. The company's gross margins are below average, reflecting sectors where input costs consume the majority of revenue. The company's operating margins are minimal, reflecting a company where overhead costs are not yet well absorbed by revenues. At this level, free cash flow is not a meaningful source of financial flexibility for the company's underlying the company. This margin configuration supports a cautious interpretation: profitability exists, though durability is less certain under stress.

Growth & Forward Outlook

On a forward-looking basis, TTM revenue growth of 57.12% a signal of strong operational momentum across the company, while the estimated 12-month price change of 31.77%, where consensus pricing assumptions suggest sizable appreciation potential. Revenue growth and price targets are correlated but not the same — strong operations do not always translate to strong price appreciation, and vice versa. The forward return case rests on whether the company can sustain their operating trajectory long enough for analyst price targets to be reached or exceeded. The estimated 12-month price change is based on analyst consensus price target estimates, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Hold

Taken together, the signals neither mandate urgency nor raise serious alarm — the profile warrants monitoring as the picture evolves.

The analysis above draws from quantitative data only and does not constitute personalized financial advice. Investors should conduct independent research and consider professional guidance before acting on any information presented here.